Headquarters
825 ALLARDICE WAY, STANFORD, CA 94305-1050, US
STANFORD, CA, US
CEREPEUT, INC.
From the company
Cerepeut is a biotechnology company developing first-in-class oral small molecule therapeutics that target mitochondrial reverse electron transport (RET) to treat neurodegeneration and age-related disease. Its lead drug candidate, CP-235, is a small molecule inhibitor of RET designed to restore mitochondrial balance and reduce oxidative stress.
Products & services offered
Capabilities 2
Classifications
- Ownership classifications (2)
- Woman Owned Business, Woman Owned Small Business
Facilities
Send your requirements
Quantities, certifications, and timing.